HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor specific reactivity during development of N-methyl-N-nitrosourea-induced rat colon cancer.

Abstract
Invasive colon adenocarcinomas with lymph node metastases can be induced in Sprague-Dawley rats by 15 weekly intrarectal injections of 2 mg N-methyl-N-nitrosourea (NMU). Extracts were prepared from invasive adenocarcinomas and normal rat colon mucosa by a 2 phase gradient. Mixed leukocyte tumor interaction (MLTI) assays stimulating lymphocytes from tumor-bearing and normal rats were performed using these extracts. Quadruplicate cultures were established with 2 X 10(5) lymphocytes and tumor or normal colon extract. Cultures were pulsed with H3 thymidine at 7 days and harvested 6 hours later. Results were expressed as net counts (experimental CPM minus background CPM). Reactivity in tumor-bearing animals was first seen when rat colons showed intraepithelial dysplasia histologically and was maximal when early invasive colon tumors were present. No difference in stimulation was seen between tumor-bearing and normal animal lymphocyte reactivity with normal colon extract. In conclusion, animals with NMU-induced rat colon cancer show specific tumor reactivity in MLTI assays. Immune reactivity in these animals may provide clues to clinical tumor status by immunologic assay.
AuthorsJ L Weese, J R Starling, S Syrjala
JournalJournal of surgical oncology (J Surg Oncol) Vol. 24 Issue 4 Pg. 277-81 (Dec 1983) ISSN: 0022-4790 [Print] United States
PMID6228694 (Publication Type: Journal Article)
Chemical References
  • Nitrosourea Compounds
  • Methylnitrosourea
Topics
  • Animals
  • Body Weight
  • Colonic Neoplasms (chemically induced, immunology, pathology)
  • Lymphocyte Culture Test, Mixed
  • Male
  • Methylnitrosourea
  • Nitrosourea Compounds
  • Probability
  • Rats
  • Rats, Inbred Strains

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: